Gene transfer into the carotid artery using an adventitial collar: comparison of the effectiveness of the plasmid-liposome complexes, retroviruses, pseudotyped retroviruses, and adenoviruses.
We studied the efficiency of plasmid/liposome complexes, Moloney murine leukemia virus-derived (MMLV) retroviruses, pseudotyped vesicular stomatitis virus protein-G (VSV-G)-containing retroviruses, and adenoviruses in delivering genes into the rabbit carotid artery using a silastic collar applied to the adventitia. This method was used for gene transfer because (a) it provides a gene delivery reservoir; (b) no intraluminal manipulations are performed; (c) installation of the collar induces arterial smooth muscle cell (SMC) proliferation and enhances retroviral gene transfer efficiency where target cell proliferation is required. The transfer of the beta-galactosidase (lacZ) marker gene to the adventitia and media occurred with all gene transfer systems. Adenoviruses also transferred the beta-galactosidase gene to some endothelial cells. After 5 days, adenoviral vectors produced the highest gene transfer efficiency with up to 10%+/-6% of cells showing beta-galactosidase activity. Pseudotyped VSV-G retroviruses were also effective in achieving gene transfer in 0.05%+/-0.03% of cells in the adventitia and media. Plasmid/liposome complexes and MMLV retroviruses infected 0.05%+/-0.03% and <0.01%+/-0.01% of cells, respectively. It is concluded that replication-deficient adenoviruses, VSV-G pseudotyped retroviruses, and plasmid/liposome complexes can be used for gene transfer to the arterial wall using the collar method. Because the endothelium remains anatomically present throughout the experiments, the model may be useful for the gene transfer studies involving diffusible or secreted gene products that primarily act on the endothelium. Effects on medial SMC and even endothelium can be achieved from the adventitial side, suggesting an alternative route for the delivery of therapeutically useful genes into the arterial wall.
Laitinen
M
M
A.I. Virtanen Institute, University of Kuopio, Finland.
Pakkanen
T
T
Donetti
E
E
Baetta
R
R
Luoma
J
J
Lehtolainen
P
P
Viita
H
H
Agrawal
R
R
Miyanohara
A
A
Friedmann
T
T
Risau
W
W
Martin
J F
JF
Soma
M
M
Ylä-Herttuala
S
S
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D002339:Carotid Arteries; D002455:Cell Division; D003238:Connective Tissue; D004730:Endothelium, Vascular; D018014:Gene Transfer Techniques; D005822:Genetic Vectors / Q000235:genetics; D007763:Lac Operon / Q000235:genetics; D008081:Liposomes / Q000008:administration & dosage*; D008562:Membrane Glycoproteins; D008979:Moloney murine leukemia virus / Q000235:genetics; D009130:Muscle, Smooth / Q000166:cytology; D010957:Plasmids; D011817:Rabbits; D012190:Retroviridae / Q000235:genetics*; D014721:Vesicular stomatitis Indiana virus / Q000235:genetics; D014759:Viral Envelope Proteins / Q000235:genetics
C028391:G protein, vesicular stomatitis virus; D008081:Liposomes; D008562:Membrane Glycoproteins; D014759:Viral Envelope Proteins